Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cervera

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Leukemia Research|June 9, 2001
Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemiaA López, J de la Rubia, G Martín, et al.
Cancer Genetics and Cytogenetics|September 15, 2007
Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangementYolanda Alvarez, M R Caballín, S Gaitán, et al.
Rehabilitacion|April 22, 2026
[Home-based rehabilitation after hip fracture: results of an integrated protocol]A Soler Ferrández, A Torrego Jiménez, E Soriano Melchor, et al.
Bone Marrow Transplantation|May 22, 2001
Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institutionG F Sanz, S Saavedra, C Jiménez, et al.
British Journal of Haematology|February 26, 2000
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética HematológicaF Solé, B Espinet, G F Sanz, et al.
Blood|October 6, 2001
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignanciesG F Sanz, S Saavedra, D Planelles, et al.
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Haematologica|August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMAJ M Hernández, G Martín, N C Gutiérrez, et al.
Leukemia|April 18, 2006
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrowW Ingram, N C Lea, J Cervera, et al.
Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Leukemia Research|June 9, 2001
Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemiaA López, J de la Rubia, G Martín, et al.
Cancer Genetics and Cytogenetics|September 15, 2007
Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangementYolanda Alvarez, M R Caballín, S Gaitán, et al.
Rehabilitacion|April 22, 2026
[Home-based rehabilitation after hip fracture: results of an integrated protocol]A Soler Ferrández, A Torrego Jiménez, E Soriano Melchor, et al.
Bone Marrow Transplantation|May 22, 2001
Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institutionG F Sanz, S Saavedra, C Jiménez, et al.
British Journal of Haematology|February 26, 2000
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética HematológicaF Solé, B Espinet, G F Sanz, et al.
Blood|October 6, 2001
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignanciesG F Sanz, S Saavedra, D Planelles, et al.
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Haematologica|August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMAJ M Hernández, G Martín, N C Gutiérrez, et al.
Leukemia|April 18, 2006
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrowW Ingram, N C Lea, J Cervera, et al.
Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.
Pageof 17